Skip to main content
All lobbying clients

SICKLE CELL DISEASE ASSOCIATION OF AMERICA

Lobbying client · Maryland · filed 2025 to 2026

national organization dedicated to supporting people living with sickle cell disease

$120,000 Reported spend
6 Filings counted
1 Firms hired
10 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (56710), not by name.

 Firms hired 1
 Bills named in these filings 10
  • S 721
    Sickle Cell Disease Comprehensive Care Act
    6 filings
  • HR 1
    For the People Act of 2021
    5 filings
  • HR 1796
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act…
    5 filings
  • S 735
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act…
    5 filings
  • HR 1509
    Accelerating Kids’ Access to Care Act of 2025
    3 filings
  • HR 247
    Health Care Affordability Act of 2025
    3 filings
  • HR 5178
    Sickle Cell Disease Comprehensive Care Act
    3 filings
  • HR 5371
    Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and E…
    3 filings
  • S 752
    Accelerating Kids’ Access to Care Act
    3 filings
  • HR 8067
    Candis King Hope for Sickle Cell Families Act
    1 filing
 Reported by year 2 years
  • 2026 $40,000 2 filings
  • 2025 $80,000 4 filings
 Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Health & Human Services, Dept of (HHS) 6
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6
  • Social Security Administration (SSA) 3

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem